List of Contents

Smart Medical Devices Market Size, Share, and Trends 2024 to 2033

Smart Medical Devices Market (By Product: Diagnostics and Monitoring, Therapeutics Devices; By End-User: Homecare Settings, Hospitals, Others; By Modality: Portable, Wearable; By Distribution Channel: Pharmacies, Online Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : April 2024
  • Report Code : 4083
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Smart Medical Devices Market 

5.1. COVID-19 Landscape: Smart Medical Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Smart Medical Devices Market, By Product

8.1. Smart Medical Devices Market Revenue and Volume Forecast, by Product, 2024-2033

8.1.1. Diagnostics and Monitoring

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Therapeutics Devices

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Smart Medical Devices Market, By End-User

9.1. Smart Medical Devices Market Revenue and Volume Forecast, by End-User, 2024-2033

9.1.1. Homecare Settings

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Hospitals

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Smart Medical Devices Market, By Modality 

10.1. Smart Medical Devices Market Revenue and Volume Forecast, by Modality, 2024-2033

10.1.1. Portable

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Wearable

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Smart Medical Devices Market, By Distribution Channel 

11.1. Smart Medical Devices Market Revenue and Volume Forecast, by Distribution Channel, 2024-2033

11.1.1. Pharmacies

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Online Channel

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Smart Medical Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by End-User (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Modality (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

Chapter 13. Company Profiles

13.1. Abbott

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Apple, Inc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Fitbit, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Dexcom, Inc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. F. Hoffmann-La Roche Ltd

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Zephyr

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Sonova, NeuroMetrix, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Medtronic

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Johnson & Johnson

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
* Immediate Delivery Available *

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us